We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi-Aventis To Launch Generic Allegra To Battle Risky Patent Challenge

Law360 (September 13, 2005, 12:00 AM EDT) -- Drug maker Sanofi-Aventis SA will launch an authorized generic version of the allergy pill Allegra in the U.S. to fight off competition from rival drug makers, which shocked analysts earlier this month with an unusually bold generic launch in the midst of a patent challenge for the $1.4 billion drug.

Sanofi-Avantis said it would launch its so-called “authorized generic” with Prasco Laboratories. The generic drug will be available in 30 mg, 60 mg and 180 mg formulations, the company said.

Financial terms of the deal were...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.